Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Animal Husbandry Group is a large Chinese state-owned agribusiness and animal health enterprise focused on animal husbandry, veterinary vaccines and pharmaceuticals, feed and feed additives, breeding stock, dairy, meat, bee products, pet products, and related logistics and trade services. The group operates as an integrated modern agriculture and animal husbandry company combining manufacturing, operations, trading, R&D, and investment activities. Its animal-health activities center on commercialized veterinary biologics and medicines rather than a human biopharma clinical pipeline. CAHG also serves as an industry platform for supply chain, international trade, and technical services across China and in more than 80 countries and regions. For a biotech analyst, the key point is that this is primarily a diversified commercial animal-health and agribusiness group, not a pure-play human therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Animal Husbandry Group.